Home › Funds › Tetragon Partners GP Ltd › DFTX
Tetragon Partners GP Ltd position in DFTX
DEFINIUM THERAPEUTICS INC · Health Care
Tetragon Partners GP Ltd reported holding 310,892 shares of DFTX (DEFINIUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$11.8M, representing 1.62% of its reported portfolio and ranking #10 among its reported holdings. Tetragon Partners GP Ltd has disclosed DFTX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Tetragon Partners GP Ltd's DFTX position evolved
Tetragon Partners GP Ltd first disclosed a stake in DFTX in Q1 2026 at 199,994 shares (US$3.8M). The position peaked in Q2 2026 at 286,990 shares, worth US$13.5M. Across 3 filings, Tetragon Partners GP Ltd increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 310,892 shares valued at US$11.8M — an increase of 23,902 shares quarter over quarter.. Notable position changes include a 43% increase in Q2 2026 (shares fell 19% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 199.99K | $3.78M | New |
| Q2 2026 | 286.99K | $13.50M | Add |
| Q3 2026 | 310.89K | $11.83M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DFTX and 13F data
DFTX (DEFINIUM THERAPEUTICS INC) is a Health Care company. 133 other funds we track also report a position in DFTX — the largest reported positions include Avoro Capital Advisors LLC (US$268.3M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$258.4M), Octagon Capital Advisors LP (US$138.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DFTX
- Avoro Capital Advisors LLC 7.05M sh · $268.32M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 6.79M sh · $258.35M · Q3 2026
- Octagon Capital Advisors LP 2.95M sh · $138.77M · Q2 2026
- Commodore Capital LP 2.00M sh · $94.08M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.50M sh · $70.56M · Q2 2026
- Boxer Capital Management, LLC 998.50K sh · $46.97M · Q2 2026
- Deep Track Capital, LP 1.00M sh · $38.06M · Q3 2026
- AWM Investment Company, Inc. 764.80K sh · $29.11M · Q3 2026
- Catalio Capital Management, LP 562.67K sh · $26.47M · Q2 2026
- GREAT POINT PARTNERS LLC 425.00K sh · $19.99M · Q2 2026
- Integral Health Asset Management, LLC 500.00K sh · $19.03M · Q3 2026
- Ally Bridge Group (NY) LLC 400.00K sh · $18.82M · Q2 2026
More on Tetragon Partners GP Ltd
FAQ
How long has Tetragon Partners GP Ltd held DFTX?
Tetragon Partners GP Ltd has disclosed DFTX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Tetragon Partners GP Ltd's current position in DFTX?
As of Q3 2026, Tetragon Partners GP Ltd holds 310.89K shares of DFTX (DEFINIUM THERAPEUTICS INC), valued at $11.83M, representing 1.62% of its reported portfolio and ranking #10.
Has Tetragon Partners GP Ltd been buying or selling DFTX?
In the latest 13F filing (Q3 2026), Tetragon Partners GP Ltd increased its position in DFTX. The position peaked in Q2 2026 at 286.99K shares.
Which other funds hold DFTX?
Other major institutional holders of DFTX include Avoro Capital Advisors LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Octagon Capital Advisors LP, among 133 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.